Review: systemic absorption of topically applied ocular drugs in humans
- PMID: 2290070
- DOI: 10.1089/jop.1990.6.243
Review: systemic absorption of topically applied ocular drugs in humans
Abstract
Literature on human plasma concentrations after instillation of ocular timolol, levobunolol, atropine, cyclopentolate, scopolamine, phenylephrine, betamethasone and technetium Tc 99m and theories of lacrimal drainage were reviewed. In all studies the eyedrops absorbed rapidly into the systemic circulation. Like the kinetics of the tracer substances in lacrimal scintigraphy, the plasma drug levels showed interindividual variations. Plasma levels of ocular drugs were lower when punctal occlusion was applied, the mechanism, however, could not be explained. Since an early and a late plasma peak was occasionally registered in some subjects in timolol and cyclopentolate studies, it is suggested that systemic absorption of ocular drugs is low during the nasolacrimal passage but occurs during conjunctival and nasal contact.
Similar articles
-
Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit.Exp Eye Res. 1993 Sep;57(3):341-9. doi: 10.1006/exer.1993.1133. Exp Eye Res. 1993. PMID: 7901046
-
Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.J Ocul Pharmacol. 1987 Summer;3(2):159-69. doi: 10.1089/jop.1987.3.159. J Ocul Pharmacol. 1987. PMID: 3503911
-
Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.J Ocul Pharmacol. 1992 Summer;8(2):91-8. doi: 10.1089/jop.1992.8.91. J Ocul Pharmacol. 1992. PMID: 1506759
-
Systemic reactions to ophthalmic drug preparations.Med Toxicol Adverse Drug Exp. 1987 Jul-Aug;2(4):287-93. doi: 10.1007/BF03259870. Med Toxicol Adverse Drug Exp. 1987. PMID: 3306268 Review.
-
Minimizing systemic absorption of topically administered ophthalmic drugs.Surv Ophthalmol. 1993 May-Jun;37(6):435-56. doi: 10.1016/0039-6257(93)90141-s. Surv Ophthalmol. 1993. PMID: 8100087 Review.
Cited by
-
Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.BMJ Case Rep. 2009;2009:bcr11.2008.1224. doi: 10.1136/bcr.11.2008.1224. Epub 2009 May 8. BMJ Case Rep. 2009. PMID: 21686405 Free PMC article.
-
In vivo drug delivery via contact lenses: The current state of the field from origins to present.J Drug Deliv Sci Technol. 2021 Jun;63:102413. doi: 10.1016/j.jddst.2021.102413. Epub 2021 Feb 18. J Drug Deliv Sci Technol. 2021. PMID: 34122626 Free PMC article.
-
Topical brinzolamide and metabolic acidosis.Br J Ophthalmol. 2006 Feb;90(2):247-8. doi: 10.1136/bjo.2005.075622. Br J Ophthalmol. 2006. PMID: 16424547 Free PMC article. No abstract available.
-
In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics.Pharmaceutics. 2020 Apr 15;12(4):360. doi: 10.3390/pharmaceutics12040360. Pharmaceutics. 2020. PMID: 32326492 Free PMC article.
-
Effect of Methylcellulose Molecular Weight on the Properties of Self-Assembling MC-g-PNtBAm Nanogels.Bioengineering (Basel). 2018 May 23;5(2):39. doi: 10.3390/bioengineering5020039. Bioengineering (Basel). 2018. PMID: 29882882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources